Prof. Dr. Mellar Davis | Pharmacology | Best Researcher Award

MD FCCP FAAHPM | Levine Cancer Institute | United States

Dr. Mellar Pilgrim Davis, MD, FCCP, FAAHPM, is a distinguished physician specializing in oncology, hematology, and palliative medicine. With decades of experience in clinical practice, research, and education, he has made significant contributions to supportive cancer care. Dr. Davis has held key academic and clinical positions at renowned institutions, impacting patient care and medical education worldwide.

Profile👤

Scopus

Strengths for the Awards✨

Extensive Research and Publications 📚
- Dr. Davis has a prolific research career, with significant contributions in oncology, palliative care, and pain management.
- Recognized as a World Expert in Analgesics (Top 0.1% of scholars per Expertscape).
- Highly ranked in Symptomatic Treatment (#4) and Palliative Care (#21) by ScholarGPS.
Significant Impact in Palliative Medicine 🌿
- Held leadership roles in the Multinational Association of Supportive Care in Cancer (MASCC), including Chair of the Pain Subgroup.
- Developed guidelines and educational programs for pain and opioid management in cancer care.
- Recognized for outstanding contributions to cancer pain management by MD Anderson Cancer Center (2023).
Recognized Excellence in Teaching and Mentorship 🎓
- Multiple Teacher of the Year awards in Cleveland Clinic and Geisinger.
- Full Professor of Palliative Medicine at Geisinger Commonwealth School of Medicine.
Leadership and Professional Influence 🌍
- Served on NCI, ASCO, ACS, and NCCN panels, shaping research and clinical practice in oncology and palliative care.
- Co-Chair of the International Conference on Opioids, advancing pain research.

Education🎓

Dr. Davis earned his Bachelor of Science degree from Otterbein College in 1974 and his MD from Ohio State Medical College in 1977. He further honed his expertise through rigorous postdoctoral training, including an Internal Medicine residency at Riverside Methodist Hospital and a Hematology/Oncology fellowship at Mayo Clinic.

Experience👩‍⚕️

Over the years, Dr. Davis has served in various prestigious medical institutions. His career journey includes roles at Toledo Clinic, Milhon Clinic, Columbus Oncology Associates, Cleveland Clinic, and Geisinger Medical Center. Additionally, he has held academic appointments as a Professor of Medicine at Cleveland Clinic Lerner School of Medicine and as a Professor of Palliative Medicine at Geisinger Commonwealth School of Medicine

Research Interests On Pharmacology

📝 Dr. Davis’s research focuses on palliative medicine, oncology symptom management, pain control, and ethical issues in cancer care. His work has influenced medical guidelines and practices worldwide, especially in the fields of palliative care and supportive oncology.

Awards and Honors🏆

Dr. Davis has received numerous awards, including the Compassion in Medicine Award, multiple “Best Doctors in America” recognitions, and the Distinguished Service Award from the Multinational Association of Supportive Care in Cancer. He has also been acknowledged as a world expert in analgesics and palliative care.

Publications📚

Are Muscle and Fat Loss Predictive of Clinical Events in Pancreatic Cancer? The Importance of Precision Metrics
- Authors: M.P. Davis, N. Bader, J.L. Basting, B. Lagerman, M.J. Wojtowicz
- Publication Year: 2025
Buprenorphine Pharmacodynamics: A Bridge to Understanding Buprenorphine Clinical Benefits
- Authors: M.P. Davis
- Publication Year: 2025
Treatment of Established Chemotherapy-Induced Neuropathy with N-Palmitoylethanolamide: A Randomized, Double-Blind Phase II Pilot Study
- Authors: M.P. Davis, A.M. Ulrich, R. Segal, B.A. Bauer, C.L. Loprinzi
- Publication Year: 2024
Respiratory Depression Associated with Opioids: A Narrative Review
- Authors: M.P. Davis, S.L. DiScala, A. Davis
- Publication Year: 2024
The Surprise Question: Not Ready for Prime Time
- Authors: M.P. Davis
- Publication Year: 2024
Correction to: Opioid Analgesic Dose and Route Conversion Ratio Studies: A Scoping Review to Inform an eDelphi Guideline
- Authors: M.P. Davis, A.N. Davies, M.L. McPherson, E.D. Bruera, C.I. Ripamonti
- Publication Year: 2024
Understanding The Number Needed to Treat
- Authors: M.P. Davis, E.A. Vanenkevort
- Publication Year: 2024
Opioid Analgesic Dose and Route Conversion Ratio Studies: A Scoping Review to Inform an eDelphi Guideline
- Authors: M.P. Davis, A.N. Davies, M.L. McPherson, E.D. Bruera, C.I. Ripamonti
- Publication Year: 2024
Fentanyl Pharmacokinetic Paradoxical in Cancer Cachexia
- Authors: M.P. Davis
- Publication Year: 2024

Conclusion🎯

Dr. Mellar Pilgrim Davis has dedicated his career to improving cancer care and palliative medicine. Through his extensive research, clinical expertise, and commitment to education, he has left an enduring impact on patient care and medical knowledge. His legacy continues to inspire healthcare professionals worldwide.

Dr. latifa khattabi | Pharmacology | Best Researcher Award

senior researcher | National Biotechnology Research Center | Algeria

Dr. Latifa Khattabi is a passionate and accomplished Permanent Researcher at the Biotechnology Research Center (CRBt) in Constantine, Algeria. Born on November 3, 1990, in El Khroub, Constantine, she has dedicated her career to the field of molecular and cellular immunology. Known for her excellence, perseverance, and ambition, Dr. Khattabi has contributed significantly to the advancement of scientific research, particularly in antioxidant, anti-inflammatory, and pharmacological studies.

Profile

Orcid

Strengths for the Awards

Academic Excellence:
- Achieved a PhD in “Molecular and Cellular Immunology” (2023) and was recognized as an “Excellent Student” during her undergraduate and master’s studies.
- Comprehensive education in immunology, oncology, and biochemistry demonstrates strong foundational expertise.
Diverse Research Contributions:
- Published over 22 scientific articles, including as a principal author, in high-impact journals.
- Research spans across immunology, biochemistry, molecular biology, and toxicology.
- Significant contributions to topics such as SARS-CoV-2, antioxidant activities, enzyme inhibition, and therapeutic plant derivatives.
Research Skills and Expertise:
- Hands-on experience in advanced techniques, including ELISA, LC-MS/MS, PCR, molecular docking, in vitro and in vivo experiments, and bioinformatics.
- Multidisciplinary approach integrating immunology, pharmacology, and analytical chemistry.
Professional Experience:
- Over a decade of research at the Biotechnology Research Center (CRBT), where she contributed to innovative projects like camelid antibodies for tuberculosis.
- Collaborated in projects involving antioxidants, anti-Alzheimer, anti-inflammatory, and antidiabetic activities, reflecting real-world applicability of her research.

Education 🎓

Dr. Khattabi has an impressive academic journey:

2023: PhD in Molecular and Cellular Immunology from University Mentouri Constantine – UMC1.
2013: Master’s Degree in Molecular and Cellular Immunology/Oncology from UMC1, graduating as an excellent student with a dissertation on thyroid cancer.
2011: Bachelor’s Degree in Molecular and Cellular Immunology, also with distinction from UMC1.
2008: Achieved her Baccalaureate in Experimental Sciences.

Experience 🌟

Dr. Khattabi has been a dedicated researcher at CRBt since 2014, excelling in areas such as:

Antioxidant, enzymatic, and toxicological assays for pharmacological studies.
Molecular biology techniques, including DNA extraction, PCR, and LC-MS/MS analysis.
In vivo experiments on animal models, focusing on toxicity and therapeutic effects.
She is also well-versed in laboratory standards, biosafety protocols, and quality assurance.

Research Interests On Pharmacology 🔬

Her primary research interests include:

Molecular immunology and its applications in oncology.
Pharmacological evaluations, including antioxidant and anti-inflammatory mechanisms.
The toxicological effects of pesticides on health and possible natural remedies.
Epidemiological studies related to cancer and chronic diseases.
Development of rapid diagnostic tools for infectious diseases like SARS-CoV-2.

Awards 🏆

Dr. Khattabi has been recognized for her outstanding contributions:

Awarded the Certificate of Excellent Student during her bachelor’s and master’s studies.
Nominee for various awards in the field of biotechnology and scientific innovation.

Publications 📚

Hydroxyphenylamine Phosphonate Derivatives
- Authors: Khattabi L., et al.
- Publication Year: 2020
- Journal: Journal of Molecular Structure
- DOI: 10.1016/j.molstruc.2020.129121
- Citations: Indexed, but specific count not provided
Distribution of Leukocyte Subpopulation Among Students Threatened by Failure
- Authors: Khattabi L., et al.
- Publication Year: 2020
- Journal: International Journal of Research in Pharmaceutical Sciences
- Citations: Not explicitly listed
Recombinant Protein Targeting and Opsonizing Spike Glycoprotein for Enhancing SARS-CoV-2 Phagocytosis
- Authors: Khattabi L., et al.
- Publication Year: 2020
- Journal: Medical Hypotheses
- DOI: 10.1016/j.mehy.2020.110108
- Citations: Indexed but count unavailable
Monomeric and Dimeric Copper (II) Complexes
- Authors: Khattabi L., et al.
- Publication Year: 2020
- Journal: Inorganica Chimica Acta
- DOI: 10.1016/j.ica.2020.119519
- Citations: Not specified
Chemical Characterization and Antioxidant Potential of Rosmarinus Tournefortii
- Authors: Khattabi L., et al.
- Publication Year: 2019
- Journal: Journal of Food Measurement and Characterization
- DOI: 10.1007/s11694-019-00309-y
- Citations: Not explicitly mentioned

Conclusion 📝

Dr. Latifa Khattabi stands out as a prolific researcher, dedicated to tackling some of the most pressing challenges in molecular immunology and pharmacology. Her dedication, versatility, and collaborative spirit have cemented her position as a key contributor to the scientific community, both in Algeria and internationally.

Mellar Davis | Pharmacology | Best Researcher Award